Sonoma Pharmaceuticals Ownership | Who Owns Sonoma Pharmaceuticals?


OverviewRevenueFinancialsChart

Sonoma Pharmaceuticals Ownership Summary


Sonoma Pharmaceuticals is owned by 6.56% institutional investors, 1.17% insiders, and 92.27% retail investors. Drw securities is the largest institutional shareholder, holding 3.56% of SNOA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.09% of its assets in Sonoma Pharmaceuticals shares.

SNOA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSonoma Pharmaceuticals6.56%1.17%92.27%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.82%11.62%67.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Drw securities60.98K3.56%$221.96K
Citadel advisors195.16K1.25%$41.41K
Vanguard group18.89K1.15%$68.75K
Geode capital management15.91K0.93%$57.91K
Mckinley carter wealth services11.19K0.68%$40.74K
State street24.32K0.16%$5.16K
Tower research capital llc (trc)1.54K0.09%$5.96K
Global retirement partners772.000.05%$2.81K
Rockefeller capital management646.000.04%$2.51K
Blackrock2.27K0.01%$481.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Drw securities60.98K0.01%$221.96K
Mckinley carter wealth services11.19K0.00%$40.74K
Tower research capital llc (trc)1.54K0.00%$5.96K
Heron bay capital management---
Blackrock2.27K-$481.00
Two sigma securities---
Renaissance---
Susquehanna group, llp---
Advisor group---
Rockefeller capital management646.00-$2.51K

Top Buyers

HolderShares% AssetsChange
Citadel advisors195.16K-195.16K
Drw securities60.98K0.01%43.91K
Mckinley carter wealth services11.19K0.00%11.19K
Rockefeller capital management646.00-646.00
Tower research capital llc (trc)1.54K0.00%536.00

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp---46.05K
Jane street group---45.30K
Heron bay capital management---33.78K
Xtx topco---19.83K
Renaissance---17.80K

New Positions

HolderShares% AssetsChangeValue
Mckinley carter wealth services11.19K0.00%11.19K$40.74K
Rockefeller capital management646.00-646.00$2.51K
Fmr2.00-2.00$7.00

Sold Out

HolderChange
Sbi securities-1.00
Allworth financial lp-3.00
Mai capital management-124.00
Advisor group-200.00
Citigroup-656.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202512-36.84%108,01081.96%650.15%3-72.73%4300.00%
Sep 30, 20251863.64%59,357-30.08%313.52%12140.00%1-50.00%
Jun 30, 202512-84,901156.84%5101.48%5-2-
Mar 31, 20251233.33%33,05663.98%2119.08%5150.00%2100.00%
Dec 31, 20249-25.00%20,159-27.39%119.10%2-60.00%1-85.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr18.79K1.09%-
Fidelity Extended Market Index10.03K0.58%1.22K
Spartan Extended Market Index Pool F3.09K0.19%62.00
Spartan Extended Market Index Pool E2.97K0.18%2.92K
Fidelity Total Market Index2.53K0.15%-
Fidelity Series Total Market Index2.31K0.13%-
Spartan Total Market Index Pool G1.04K0.06%224.00
Fidelity Nasdaq Composite Index248.000.02%-
Northern Trust Extended Eq Market Idx96.000.01%-
NT Ext Equity Mkt Idx Fd - L96.000.01%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 12, 2018Miller Robert E Chief Financial OfficerBuy$4.84K
Mar 13, 2018Miller Robert E Chief Financial OfficerBuy$4.92K
Mar 12, 2018Miller Robert E Chief Financial OfficerBuy$4.84K
Mar 09, 2018Miller Robert E Chief Financial OfficerBuy$4.68K
Mar 08, 2018Schutz James J Chief Executive OfficerBuy$9.87K

Insider Transactions Trends


DateBuySell
2027 Q1--
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q2--

SNOA Ownership FAQ


Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals shareholders are primarily institutional investors at 6.56%, followed by 1.17% insiders and 92.27% retail investors. The average institutional ownership in Sonoma Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Sonoma Pharmaceuticals falls below.

Who owns the most shares of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals’s largest shareholders are Drw securities (60.98K shares, 3.56%), Citadel advisors (195.16K shares, 1.25%), and Vanguard group (18.89K shares, 1.15%). Together, they hold 5.96% of Sonoma Pharmaceuticals’s total shares outstanding.

Does Blackrock own Sonoma Pharmaceuticals?

Yes, BlackRock owns 0.01% of Sonoma Pharmaceuticals, totaling 2.27K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 481$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Drw securities is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 60.98K Sonoma Pharmaceuticals shares, valued at 221.96K$.

Who is the top mutual fund holder of Sonoma Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Sonoma Pharmaceuticals shares, with 1.09% of its total shares outstanding invested in 18.79K Sonoma Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools